Francesco Marampon

Pubblicazioni

Titolo Pubblicato in Anno
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models ONCOTARGET 2017
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models TUMOR BIOLOGY 2017
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study EUROPEAN JOURNAL OF HISTOCHEMISTRY 2017
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer ONCOTARGET 2017
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR ser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy ONCOTARGET 2017
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage ONCOTARGET 2016
c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines RADIATION RESEARCH 2016
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: a retrospective study by propensity analysis ONCOLOGY LETTERS 2016
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population MOLECULAR CANCER 2016
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2016
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation ONCOTARGET 2016
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results ONCOTARGET 2016
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models TUMOR BIOLOGY 2016
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer ONCOLOGY REPORTS 2016
EPHA2 inhibition reverts epithelial-mesenchymal transition (EMT) phenotype and reduces proliferation of colorectal cancer cells Novel diagnostic and therapeutic strategies for cancer, immunological disorders and rare diseases 2016
Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: propensity matching analysis in 175 patients PLOS ONE 2015
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models BMC CANCER 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma